Sarah is a Senior Biostatistician at the Cancer Research UK Clinical Trials Unit (CRCTU). She joined the unit in 2006, with a focus on breast and urological cancers. Her research interest is in phase III clinical trial methodology for de-escalation trials.
Sarah is a co-investigator on clinical trials in breast cancer, DCIS and bladder cancer. She also acts as trial statistician for clinical trials in renal cancer, Hodgkin’s lymphoma and prostate cancer.